Please Wait.....
Report
Asia-Pacific Immunoglobulin Market Forecast 2022-2030
Market Report I 2022-06-28 I 168 Pages I Inkwood Research
KEY FINDINGS
The Asia-Pacific immunoglobulin market is estimated to grow with a CAGR of 7.20% during the forecast period of 2022 to 2030. The market growth of the region is fuelled by the launch of advanced and innovative immunoglobulin products, the rise in the geriatric population, and the increasing incidence of various disease types.
MARKET INSIGHTS
The Asia-Pacific immunoglobulin market growth assessment entails the evaluation of China, South Korea, Indonesia, Vietnam, Japan, India, Australia, Thailand, and Rest of Asia-Pacific. Key players are engaged in the launch and development of innovative immunoglobulin products in India. For example, Cipla, in 2021, launched Roche's COVID antibody cocktail (Imdevimab and Casirivimab) in the country. It is administered for treating moderate to mild COVID-19 in adults and pediatric patients. Casirivimab, as well as Imdevimab, entail human immunoglobulin G-1 (IgG1) monoclonal antibodies produced by recombinant DNA technology in laboratories.
Conversely, there has been a substantial rise in healthcare expenditure in Indonesia. As a result, patients experiencing various types of immunodeficiency diseases and other rare conditions gain fast and easy access to technologically advanced and novel healthcare facilities. Moreover, this factor not only helps in the effective diagnosis but also facilitates improved treatment for numerous disease types. Therefore, these factors are anticipated to propel the market growth in the Asia-Pacific during the forecast period.
COMPETITIVE INSIGHTS
Prominent companies operating in the market include Sichuan Yuanda Shuyang Pharmaceutical Co Ltd, Takeda Pharmaceutical Company Limited, Shanghai RAAS Blood Products Co Ltd, etc.
Our report offerings include:
- Explore key findings of the overall market
- Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
- Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
- Market Segmentation cater to a thorough assessment of key segments with their market estimations
- Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
- Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
- Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
- Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. GROWTH IN GERIATRIC POPULATION
3.1.2. PREVALENCE OF IMMUNODEFICIENCY DISEASES AND AUTOIMMUNE DISORDERS
3.1.3. INCREASING RESEARCH AND DEVELOPMENT ACTIVITIES
3.2. KEY RESTRAINTS
3.2.1. HIGH COST OF THERAPY
3.2.2. HIGH RISK OF SIDE EFFECTS
4. KEY ANALYTICS
4.1. IMPACT OF COVID-19 ON IMMUNOGLOBULIN MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER'S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE
4.6. KEY BUYING CRITERIA
4.6.1. SOURCE
4.6.2. APPLICATION
4.6.3. EPITOPE
4.6.4. VALIDATION
4.7. REGULATORY FRAMEWORK
5. MARKET BY PRODUCT
5.1. IGG
5.2. IGA
5.3. IGM
5.4. IGE
5.5. IGD
6. MARKET BY MODE OF DELIVERY
6.1. INTRAVENOUS IMMUNOGLOBULIN
6.2. SUBCUTANEOUS IMMUNOGLOBULIN
6.3. INTRAMUSCULAR IMMUNOGLOBULIN
7. MARKET BY APPLICATION
7.1. HYPOGAMMA GLOBULINEMIA
7.2. CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
7.3. PRIMARY IMMUNODEFICIENCY DISEASES
7.4. MYASTHENIA GRAVIS
7.5. MULTIFOCAL MOTOR NEUROPATHY
7.6. IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP)
7.7. INFLAMMATORY MYOPATHIES
7.8. SPECIFIC ANTIBODY DEFICIENCY
7.9. GUILLAIN-BARRE SYNDROME
7.10. OTHER APPLICATIONS
8. MARKET BY DISTRIBUTION CHANNEL
8.1. HOSPITAL PHARMACY
8.2. SPECIALTY PHARMACY
8.3. OTHER DISTRIBUTION CHANNELS
9. MARKET BY END-USER
9.1. HOSPITALS & CLINICS
9.2. HOMECARE
10. GEOGRAPHICAL ANALYSIS
10.1. ASIA-PACIFIC
10.1.1. MARKET SIZE & ESTIMATES
10.1.2. KEY GROWTH ENABLERS
10.1.3. KEY CHALLENGES
10.1.4. KEY PLAYERS
10.1.5. COUNTRY ANALYSIS
10.1.5.1. CHINA
10.1.5.2. JAPAN
10.1.5.3. INDIA
10.1.5.4. SOUTH KOREA
10.1.5.5. INDONESIA
10.1.5.6. THAILAND
10.1.5.7. VIETNAM
10.1.5.8. AUSTRALIA
10.1.5.9. REST OF ASIA-PACIFIC
11. COMPETITIVE LANDSCAPE
11.1. KEY STRATEGIC DEVELOPMENTS
11.1.1. MERGERS & ACQUISITIONS
11.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
11.1.3. PARTNERSHIPS & AGREEMENTS
11.1.4. BUSINESS EXPANSIONS & DIVESTITURES
11.2. COMPANY PROFILES
11.2.1. ADMA BIOLOGICS
11.2.2. BIO PRODUCTS LABORATORY
11.2.3. BIOTEST AG
11.2.4. CHINA BIOLOGIC PRODUCTS INC
11.2.5. CSL BEHRING
11.2.6. GRIFOLS SA
11.2.7. KAMADA LTD
11.2.8. KEDRION BIOPHARMA
11.2.9. LFB GROUP
11.2.10. OCTAPHARMA AG
11.2.11. PFIZER INC
11.2.12. SANQUIN PLASMA PRODUCTS BV
11.2.13. SHANGHAI RAAS BLOOD PRODUCTS CO LTD
11.2.14. SICHUAN YUANDA SHUYANG PHARMACEUTICAL CO LTD
11.2.15. TAKEDA PHARMACEUTICAL COMPANY LIMITED
LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - IMMUNOGLOBULIN
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: ASIA-PACIFIC IMMUNOGLOBULIN MARKET, BY PRODUCT, HISTORICAL YEARS 2018-2021 (IN $ MILLION)
TABLE 4: ASIA-PACIFIC IMMUNOGLOBULIN MARKET, BY PRODUCT, FORECAST YEARS 2022-2030 (IN $ MILLION)
TABLE 5: ASIA-PACIFIC IMMUNOGLOBULIN MARKET, BY MODE OF DELIVERY, HISTORICAL YEARS 2018-2021 (IN $ MILLION)
TABLE 6: ASIA-PACIFIC IMMUNOGLOBULIN MARKET, BY MODE OF DELIVERY, FORECAST YEARS 2022-2030 (IN $ MILLION)
TABLE 7: ASIA-PACIFIC IMMUNOGLOBULIN MARKET, BY APPLICATION, HISTORICAL YEARS 2018-2021 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC IMMUNOGLOBULIN MARKET, BY APPLICATION, FORECAST YEARS 2022-2030 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC IMMUNOGLOBULIN MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS 2018-2021 (IN $ MILLION)
TABLE 10: ASIA-PACIFIC IMMUNOGLOBULIN MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS 2022-2030 (IN $ MILLION)
TABLE 11: ASIA-PACIFIC IMMUNOGLOBULIN MARKET, BY END-USER, HISTORICAL YEARS 2018-2021 (IN $ MILLION)
TABLE 12: ASIA-PACIFIC IMMUNOGLOBULIN MARKET, BY END-USER, FORECAST YEARS 2022-2030 (IN $ MILLION)
TABLE 13: ASIA-PACIFIC IMMUNOGLOBULIN MARKET, BY COUNTRY, HISTORICAL YEARS 2018-2021 (IN $ MILLION)
TABLE 14: ASIA-PACIFIC IMMUNOGLOBULIN MARKET, BY COUNTRY, FORECAST YEARS 2022-2030 (IN $ MILLION)
TABLE 15: LEADING PLAYERS OPERATING IN ASIA-PACIFIC IMMUNOGLOBULIN MARKET
TABLE 16: LIST OF MERGERS & ACQUISITIONS
TABLE 17: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 18: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 19: LIST OF BUSINESS EXPANSIONS & DIVESTITURES
LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: KEY BUYING CRITERIA
FIGURE 6: ASIA-PACIFIC IMMUNOGLOBULIN MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2021
FIGURE 7: ASIA-PACIFIC IMMUNOGLOBULIN MARKET, BY IGG, 2022-2030 (IN $ MILLION)
FIGURE 8: ASIA-PACIFIC IMMUNOGLOBULIN MARKET, BY IGA, 2022-2030 (IN $ MILLION)
FIGURE 9: ASIA-PACIFIC IMMUNOGLOBULIN MARKET, BY IGM, 2022-2030 (IN $ MILLION)
FIGURE 10: ASIA-PACIFIC IMMUNOGLOBULIN MARKET, BY IGE, 2022-2030 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC IMMUNOGLOBULIN MARKET, BY IGD, 2022-2030 (IN $ MILLION)
FIGURE 12: ASIA-PACIFIC IMMUNOGLOBULIN MARKET, GROWTH POTENTIAL, BY MODE OF DELIVERY, IN 2021
FIGURE 13: ASIA-PACIFIC IMMUNOGLOBULIN MARKET, BY INTRAVENOUS IMMUNOGLOBULIN, 2022-2030 (IN $ MILLION)
FIGURE 14: ASIA-PACIFIC IMMUNOGLOBULIN MARKET, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2022-2030 (IN $ MILLION)
FIGURE 15: ASIA-PACIFIC IMMUNOGLOBULIN MARKET, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2022-2030 (IN $ MILLION)
FIGURE 16: ASIA-PACIFIC IMMUNOGLOBULIN MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2021
FIGURE 17: ASIA-PACIFIC IMMUNOGLOBULIN MARKET, BY HYPOGAMMA GLOBULINEMIA, 2022-2030 (IN $ MILLION)
FIGURE 18: ASIA-PACIFIC IMMUNOGLOBULIN MARKET, BY CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY, 2022-2030 (IN $ MILLION)
FIGURE 19: ASIA-PACIFIC IMMUNOGLOBULIN MARKET, BY PRIMARY IMMUNODEFICIENCY DISEASES, 2022-2030 (IN $ MILLION)
FIGURE 20: ASIA-PACIFIC IMMUNOGLOBULIN MARKET, BY MYASTHENIA GRAVIS, 2022-2030 (IN $ MILLION)
FIGURE 21: ASIA-PACIFIC IMMUNOGLOBULIN MARKET, BY MULTIFOCAL MOTOR NEUROPATHY, 2022-2030 (IN $ MILLION)
FIGURE 22: ASIA-PACIFIC IMMUNOGLOBULIN MARKET, BY IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP), 2022-2030 (IN $ MILLION)
FIGURE 23: ASIA-PACIFIC IMMUNOGLOBULIN MARKET, BY INFLAMMATORY MYOPATHIES, 2022-2030 (IN $ MILLION)
FIGURE 24: ASIA-PACIFIC IMMUNOGLOBULIN MARKET, BY SPECIFIC ANTIBODY DEFICIENCY, 2022-2030 (IN $ MILLION)
FIGURE 25: ASIA-PACIFIC IMMUNOGLOBULIN MARKET, BY GUILLAIN-BARRE SYNDROME, 2022-2030 (IN $ MILLION)
FIGURE 26: ASIA-PACIFIC IMMUNOGLOBULIN MARKET, BY OTHER APPLICATIONS, 2022-2030 (IN $ MILLION)
FIGURE 27: ASIA-PACIFIC IMMUNOGLOBULIN MARKET, GROWTH POTENTIAL, BY DISTRIBUTION CHANNEL, IN 2021
FIGURE 28: ASIA-PACIFIC IMMUNOGLOBULIN MARKET, BY HOSPITAL PHARMACY, 2022-2030 (IN $ MILLION)
FIGURE 29: ASIA-PACIFIC IMMUNOGLOBULIN MARKET, BY SPECIALTY PHARMACY, 2022-2030 (IN $ MILLION)
FIGURE 30: ASIA-PACIFIC IMMUNOGLOBULIN MARKET, BY OTHER DISTRIBUTION CHANNELS, 2022-2030 (IN $ MILLION)
FIGURE 31: ASIA-PACIFIC IMMUNOGLOBULIN MARKET, GROWTH POTENTIAL, BY END-USER, IN 2021
FIGURE 32: ASIA-PACIFIC IMMUNOGLOBULIN MARKET, BY HOSPITALS & CLINICS, 2022-2030 (IN $ MILLION)
FIGURE 33: ASIA-PACIFIC IMMUNOGLOBULIN MARKET, BY HOMECARE, 2022-2030 (IN $ MILLION)
FIGURE 34: ASIA-PACIFIC IMMUNOGLOBULIN MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 35: CHINA IMMUNOGLOBULIN MARKET, 2022-2030 (IN $ MILLION)
FIGURE 36: JAPAN IMMUNOGLOBULIN MARKET, 2022-2030 (IN $ MILLION)
FIGURE 37: INDIA IMMUNOGLOBULIN MARKET, 2022-2030 (IN $ MILLION)
FIGURE 38: SOUTH KOREA IMMUNOGLOBULIN MARKET, 2022-2030 (IN $ MILLION)
FIGURE 39: INDONESIA IMMUNOGLOBULIN MARKET, 2022-2030 (IN $ MILLION)
FIGURE 40: THAILAND IMMUNOGLOBULIN MARKET, 2022-2030 (IN $ MILLION)
FIGURE 41: VIETNAM IMMUNOGLOBULIN MARKET, 2022-2030 (IN $ MILLION)
FIGURE 42: AUSTRALIA IMMUNOGLOBULIN MARKET, 2022-2030 (IN $ MILLION)
FIGURE 43: REST OF ASIA-PACIFIC IMMUNOGLOBULIN MARKET, 2022-2030 (IN $ MILLION)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security